News

J&J Will Enroll 60,000 COVID-19 Vaccine Trial Participants

Written by Yourway | September 29, 2020

Johnson & Johnson will enroll 60,000 trial participants in COVID-19 clinical trials. The company has said it will know if the vaccine is effective by the end of this year. The vaccine is differentiated from competitors because it requires only one dose instead of two and will not require freezing. The trials will take place in the United States, Argentina, Brazil, Chile, Colombia, Mexico, Peru, and South Africa. Yourway has a global presence and depots located around the world – because of our over 20 strategically located depot facilities, we get your clinical materials around the world in hours, not days.